Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.460
-0.060 (-1.70%)
At close: Mar 6, 2026, 4:00 PM EST
3.500
+0.040 (1.16%)
After-hours: Mar 6, 2026, 6:41 PM EST

CPIX Revenue

Cumberland Pharmaceuticals had revenue of $13.68M in the quarter ending December 31, 2025, with 31.08% growth. This brings the company's revenue in the last twelve months to $41.28M, up 12.21% year-over-year. In the year 2024, Cumberland Pharmaceuticals had annual revenue of $37.87M, down -4.26%.

Revenue (ttm)
$41.28M
Revenue Growth
+12.21%
P/S Ratio
1.27
Revenue / Employee
$453,608
Employees
91
Market Cap
52.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202437.87M-1.68M-4.26%
Dec 31, 202339.55M-2.46M-5.85%
Dec 31, 202242.01M6.03M16.75%
Dec 31, 202135.99M-1.46M-3.89%
Dec 31, 202037.44M3.05M8.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 137.35M
Rockwell Medical 75.58M
InterCure 72.16M
Aytu BioPharma 62.64M
Zhengye Biotechnology Holding 21.46M
SCYNEXIS 20.60M
TherapeuticsMD 2.80M
BioXcel Therapeutics 752.00K
Revenue Rankings